A Y1 receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer

Yinjie Wang, Zhenqi Jiang, Bo Yuan, Yuchen Tian, Lingchao Xiang, Yanying Li, Yong Yang, Juan Li and Aiguo Wu

Biomater. Sci., 2019, 7, 4748
DOI: 10.1039/C9BM00337A

Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies

Manuel Lisardo Sánchez, Francisco D. Rodríguez and Rafael Coveñas

IJMS, 2023, 24, 9962
DOI: 10.3390/ijms24129962

Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors

Yixin Shi, Ziren Kong, Penghao Liu, Guozhu Hou, Jiaming Wu, Wenbin Ma, Xin Cheng and Yu Wang

Cells, 2021, 10, 1142
DOI: 10.3390/cells10051142

Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple‐Negative Breast Cancer

Yi Cao, Xiaojiao Ge, Xueli Zhu, Yingying Han, Pin Wang, Ozioma Udochukwu Akakuru, Aiguo Wu and Juan Li

Advanced Science, 2023, 10
DOI: 10.1002/advs.202300545

A D-peptide ligand of neuropeptide Y receptor Y1 serves as nanocarrier traversing of the blood brain barrier and targets glioma

Yanying Li, Yuanbo Pan, Yinjie Wang, Zhenqi Jiang, Ozioma U. Akakuru, Mingli Li, Xianyun Zhang, Bo Yuan, Jie Xing, Lijia Luo, Dan Larhammar, Aiguo Wu and Juan Li

Nano Today, 2022, 44, 101465
DOI: 10.1016/j.nantod.2022.101465

Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo

Zhenqi Jiang, Yinjie Wang, Li Sun, Bo Yuan, Yuchen Tian, Lingchao Xiang, Yanying Li, Yong Li, Juan Li and Aiguo Wu

Biomaterials, 2019, 197, 41
DOI: 10.1016/j.biomaterials.2019.01.001

Combined Strategies for Nanodrugs Noninvasively Overcoming the Blood–Brain Barrier and Actively Targeting Glioma Lesions

Yuanyuan Liu, Haigang Wu and Gaofeng Liang

Biomater Res, 2025, 29
DOI: 10.34133/bmr.0133

Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma

David Aebisher, Paweł Woźnicki, Magdalena Czarnecka-Czapczyńska, Klaudia Dynarowicz, Ewelina Szliszka, Aleksandra Kawczyk-Krupka and Dorota Bartusik-Aebisher

IJMS, 2024, 25, 8708
DOI: 10.3390/ijms25168708

Dual and multi-targeted nanoparticles for site-specific brain drug delivery

Yan Luo, Hang Yang, Yi-Fan Zhou and Bo Hu

Journal of Controlled Release, 2020, 317, 195
DOI: 10.1016/j.jconrel.2019.11.037

Strategies for improving stability and pharmacokinetic characteristics of radiolabeled peptides for imaging and therapy

Nasrin Abbasi Gharibkandi, J. Michael Conlon and Seyed Jalal Hosseinimehr

Peptides, 2020, 133, 170385
DOI: 10.1016/j.peptides.2020.170385

Advanced nanomicelles for targeted glioblastoma multiforme therapy

P. Chithra, Dhiraj Bhatia and Raghu Solanki

Biomaterials Advances, 2025, 170, 214221
DOI: 10.1016/j.bioadv.2025.214221

Renal-Clearable Peptide-Functionalized Ba2GdF7 Nanoparticles for Positive Tumor-Targeting Dual-Mode Bioimaging

Yang Feng, Hongda Chen, Baiqi Shao, Shuang Zhao, Zhenxin Wang and Hongpeng You

ACS Appl. Mater. Interfaces, 2018, 10, 25511
DOI: 10.1021/acsami.8b07129

Chiral helical peptide nanomaterials: Construction strategies and applications

Shiwei Wang, Zhen He, Xiaolin Duan, Lulu He, Jie Xing, Aiguo Wu and Juan Li

Nano Today, 2025, 62, 102703
DOI: 10.1016/j.nantod.2025.102703

Chemotherapeutic nanomaterials in tumor boundary delineation: Prospects for effective tumor treatment

Ozioma Udochukwu Akakuru, Zhoujing Zhang, M. Zubair Iqbal, Chengjie Zhu, Yewei Zhang and Aiguo Wu

Acta Pharmaceutica Sinica B, 2022, 12, 2640
DOI: 10.1016/j.apsb.2022.02.016

Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment

Agata M. Gawel, Anna Betkowska, Ewa Gajda, Marlena Godlewska and Damian Gawel

Biomedicines, 2024, 12, 1822
DOI: 10.3390/biomedicines12081822

Nanoparticle delivery systems for substance use disorder

Vishal Kasina, Robert J. Mownn, Raman Bahal and Gregory C. Sartor

Neuropsychopharmacol., 2022, 47, 1431
DOI: 10.1038/s41386-022-01311-7

Glioma and Peptidergic Systems: Oncogenic and Anticancer Peptides

Manuel Lisardo Sánchez, Arturo Mangas and Rafael Coveñas

IJMS, 2024, 25, 7990
DOI: 10.3390/ijms25147990

Targeting of peptide‐binding receptors on cancer cells with peptide‐drug conjugates

Dennis J. Worm, Sylvia Els‐Heindl and Annette G. Beck‐Sickinger

Peptide Science, 2020, 112
DOI: 10.1002/pep2.24171

Application of Polymer Materials in Targeting Glioma

Jia Guo, Zheng Yao, Feiyu Zhang and Junzi Wu

ACAMC, 2023, 23, 1284
DOI: 10.2174/1871520623666230222142825

Recent progress on near‐infrared fluorescence heptamethine cyanine dye‐based molecules and nanoparticles for tumor imaging and treatment

Yue Qiu, Bo Yuan, Yi Cao, Xuelu He, Ozioma Udochukwu Akakuru, Liheng Lu, Nengwen Chen, Mengting Xu, Aiguo Wu and Juan Li

WIREs Nanomed Nanobiotechnol, 2023, 15
DOI: 10.1002/wnan.1910